Getting off an SSRI safely requires a slow, gradual taper rather than stopping abruptly. Most people who’ve taken an SSRI for more than a few weeks will need to reduce their dose in stages over weeks to months, with the final reductions being the smallest and slowest. Stopping cold turkey or tapering too quickly is the most common reason people experience uncomfortable withdrawal symptoms or give up on discontinuation altogether.
Why You Can’t Just Stop
SSRIs work by blocking the brain’s serotonin recycling system, which floods the gaps between nerve cells with extra serotonin. Within just a few weeks on the medication, your brain adapts to this higher serotonin level by reducing the number and sensitivity of its serotonin receptors. Brain imaging studies have confirmed this change in living patients.
When you remove the drug suddenly, serotonin levels drop, but your receptors don’t bounce back at the same speed. That mismatch between low serotonin activity and downregulated receptors is what drives withdrawal symptoms. Your brain needs time to rebuild its receptor landscape, and that process can’t be rushed by willpower or supplements alone.
What Withdrawal Feels Like
Symptoms typically begin within two to four days of stopping or sharply reducing your dose. Clinicians use the mnemonic FINISH to describe the cluster of symptoms:
- Flu-like symptoms: fatigue, headache, body aches, sweating
- Insomnia: difficulty sleeping, vivid dreams, nightmares
- Nausea: sometimes with vomiting
- Imbalance: dizziness, vertigo, light-headedness
- Sensory disturbances: burning, tingling, or “brain zaps” (brief electric shock-like sensations)
- Hyperarousal: anxiety, irritability, agitation
Most cases are mild and resolve within eight weeks. But not all. One study tracking people after discontinuation found that 7% still had symptoms at two months, 6% at one year, and 2% beyond three years. The severity and duration depend partly on how long you were on the medication, your dose, and which specific SSRI you’re taking.
Why Your Specific SSRI Matters
Not all SSRIs leave your body at the same rate. Fluoxetine has a half-life of two to four days, and its active byproduct lingers for seven to fifteen days. Every other common SSRI has a half-life of roughly one day. This means fluoxetine effectively tapers itself as it slowly clears your system, making abrupt discontinuation less jarring. Paroxetine, by contrast, is notorious for difficult withdrawal because it leaves the body quickly and has additional effects on brain chemistry beyond serotonin.
If you’re on a shorter-acting SSRI like sertraline, paroxetine, or escitalopram, you’ll generally need a more careful and extended taper than someone coming off fluoxetine.
How Hyperbolic Tapering Works
The most important thing to understand about tapering is that the relationship between dose and brain effect is not linear. A drop from 100 mg to 50 mg does not feel the same as a drop from 50 mg to zero, even though both are 50 mg reductions. At lower doses, each milligram removed has a proportionally larger impact on receptor activity. This is why so many people taper successfully down to a low dose and then hit a wall when they try to stop completely.
Hyperbolic tapering addresses this by making each reduction smaller than the last. Instead of cutting the same number of milligrams each time, you might reduce by 50% of your current dose in the early stages, then 25%, then 10%, getting down to very small final doses. The Royal College of Psychiatrists recommends tapering over months or years for people who have been on antidepressants long-term, going down to doses under 1 mg before stopping entirely, and adjusting the pace to whatever you can tolerate.
A practical example: someone on 20 mg of citalopram might step down to 10 mg, then 5 mg, then 2.5 mg, then 1 mg, then 0.5 mg, with each step lasting several weeks. The final reductions look tiny on paper but represent significant changes in brain chemistry.
Getting Small Enough Doses
Standard pill sizes often can’t get you to the low doses a hyperbolic taper requires. This is where liquid formulations become essential. About five SSRIs are available in liquid form in the United States. Citalopram, for instance, comes as a liquid at 2 mg per milliliter. Using a small oral syringe, you can measure doses anywhere from 0.2 mg to 40 mg. For even finer adjustments, the liquid can be diluted further with water to reach doses as low as 0.02 mg.
If your SSRI isn’t available as a liquid, some tablets are dispersible (they dissolve in water) or crushable, which allows you to create a suspension and measure small doses. Your pharmacist can help you figure out what’s possible with your specific medication. Pill splitting with a tablet cutter works for moderate reductions but becomes impractical below a certain point.
The Fluoxetine Bridge Strategy
For people who struggle to taper off shorter-acting SSRIs, one approach involves temporarily switching to fluoxetine. Because fluoxetine leaves the body so slowly, it creates a natural cushion against withdrawal. The general process works in four steps: taper your original SSRI to the lowest tolerable dose, add a low dose of fluoxetine (typically 5 mg per day) while keeping the original drug for about four weeks, then stop the original SSRI and gradually taper the fluoxetine.
As a concrete example, someone tapering off sertraline 100 mg might reduce to 50 mg, then 25 mg, then 12.5 mg over several months. If withdrawal hits after stopping the 12.5 mg dose, they’d restart at 12.5 mg, add fluoxetine 5 mg daily for four weeks, then stop the sertraline and slowly reduce fluoxetine over several more months, stepping down to weekly dosing before stopping. The entire process in this scenario takes around 34 weeks. It’s not fast, but in a study of 41 patients who had failed a first taper attempt with paroxetine, none had a recurrence after using a slower retitration or switching strategy.
How to Reduce Your Relapse Risk
One of the biggest concerns about stopping an SSRI isn’t withdrawal, it’s the return of the depression or anxiety the medication was treating. The numbers here are sobering but also show a clear path forward. In studies comparing different approaches, people who tapered with only basic medical management had relapse rates of 35% to 80% within two years. People who added cognitive behavioral therapy (CBT) to their taper had relapse rates of just 15% to 25% over the same period.
Even at the six-year mark, the CBT advantage held: 40% to 50% relapse with therapy versus 75% to 90% without. Mindfulness-based cognitive therapy showed similar protective effects, with relapse rates comparable to staying on antidepressants long-term (roughly 44% to 54% at 15 months).
The takeaway is straightforward. If you’re planning to come off an SSRI, building psychological skills before and during your taper substantially improves your odds of staying well. Starting therapy several months before you begin reducing your dose gives you time to develop these tools while you still have the medication’s support.
What Helps During the Taper
Exercise, sleep consistency, and stress reduction are the standard non-negotiable supports during a taper, but there’s also reasonable evidence for magnesium supplementation. In a randomized trial, people taking SSRIs who added 250 mg of magnesium daily for six weeks showed significantly lower depression scores compared to a placebo group by weeks four and six. Multiple other trials using 250 to 500 mg daily have found similar mood benefits, with one researcher noting that patients already on antidepressants seemed to benefit more from magnesium than those who weren’t.
Magnesium isn’t a replacement for a careful taper, but it may provide a modest buffer for mood stability during the process. It’s inexpensive, widely available, and well tolerated at these doses for most people.
Setting Realistic Expectations
A successful taper is rarely a straight line. Most people hit at least one point where they need to pause at a dose for longer than planned, or even step back up temporarily before continuing down. This isn’t failure. It’s the process working as intended. The pace should be dictated by how you feel, not by a rigid calendar.
For someone who’s been on an SSRI for a year or two, a three- to six-month taper is common. For people on higher doses or longer treatment courses, a taper stretching beyond a year is reasonable. The goal is to give your brain enough time at each step to recalibrate before you ask it to adjust again. Keeping a simple daily log of your symptoms, even just a 1-to-10 rating, helps you and your prescriber make informed decisions about when to hold, reduce, or pause.